טוען...
Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)
There are limited studies assessing the live attenuated varicella vaccine following alloHCT. Due to the morbidity of varicella acquired after childhood, we immunized and retrospectively analyzed the safety and immunogenicity of this vaccine in 46 VZV seronegative patients <20 years old at HCT who...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3660138/ https://ncbi.nlm.nih.gov/pubmed/21664979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.05.006 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|